Company research / VRCA
Verrica Pharmaceuticals Inc. (VRCA)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Verrica Pharmaceuticals Inc. reported revenue of $35.58M. Revenue grew 370.2% from the prior annual period.
Key ratios (year ended 2025-12-31)
-34.2%
Operating margin
-50.3%
Net margin
-72.3%
Return on year-end equity
370.2%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.